Prevalence of QTc prolongation in breast cancer patients and the risk factors
- VernacularTitle:乳腺癌患者QTc延长的发生率及其影响因素分析
- Author:
Hua QIAN
1
;
Mingyue TAN
2
;
Wenyuan LI
2
;
Guoliang LI
2
;
Yan LIU
1
Author Information
- Publication Type:Journal Article
- Keywords: breast cancer; QTc; anthracycline; risk factor
- From: Journal of Xi'an Jiaotong University(Medical Sciences) 2022;43(3):426-429
- CountryChina
- Language:Chinese
- Abstract: 【Objective】 To investigate the prevalence of QTc prolongation and the risk factors in hospitalized breast cancer patients. 【Methods】 A total of 296 patients with pathologically diagnosed breast cancer admitted to The First Affiliated Hospital of Xi’an Jiaotong University in 2018 were retrospectively enrolled. The patients’ baseline data， 12-lead ECG， the prevalence of QTc （QTc max） prolongation and its risk factors were analyzed by the multivariate logistic regression. 【Results】 The prevalence of QTc prolongation in the hospitalized breast cancer patients was 13%； multivariate logistic regression analysis showed that increased heart rate （OR=1.04， P<0.05）， combined hypertension （OR=6.48， P<0.05）， and anthracycline administration （OR=3.96， P<0.05） were the risk factors of the prolongation of QTc interval in the breast cancer patients （P<0.05）. 【Conclusion】 The prevalence of prolonged QTc interval in the hospitalized breast cancer patients is increased， which may be due to the increased heart rate， hypertension， and the administration of anthracycline drugs in these patients.
